Clinical Trials on Advanced or Refractory Solid Malignancies
Total 3564 results
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid MalignanciesUnited States
-
Novita Pharmaceuticals, Inc.RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingAdvanced Or Metastatic Solid Tumor MalignanciesChina
-
GigaGen, Inc.National Cancer Institute (NCI)RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
Bristol-Myers SquibbCompletedHER2 or EGFR Expressing Advanced Solid MalignanciesSpain, France
-
Kiromic, Inc.TerminatedCancer | Progressive Solid Malignancies | Refractory Solid MalignanciesUnited States
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
AHS Cancer Control AlbertaCross Cancer InstituteWithdrawnMetastatic Solid Malignancies | Locally Advanced Solid MalignanciesCanada
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesChina
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesUnited States
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
Athenex, Inc.RecruitingAdvanced Solid MalignanciesUnited States
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesFrance, Spain, Canada
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
Taipei Medical UniversityCompletedAdvanced Solid MalignanciesTaiwan
-
Hanmi Pharmaceutical Company LimitedCompletedAdvanced Solid MalignanciesKorea, Republic of
-
AstraZenecaCompleted10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid MalignanciesAdvanced Solid MalignanciesChina
-
Bristol-Myers SquibbTerminatedAdvanced Solid MalignanciesUnited States, Canada
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesRomania, Moldova, Republic of
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesNetherlands
-
Samyang Biopharmaceuticals CorporationCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Solid MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
Mayo ClinicGlaxoSmithKlineCompletedAdvanced Solid MalignanciesUnited States
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
BioRay Pharmaceutical Co., Ltd.Not yet recruitingAdvanced Solid MalignanciesChina
-
Georgiamune IncRecruitingAdvanced Solid MalignanciesUnited States
-
Treadwell Therapeutics, IncTIO Discovery EngineRecruitingAdvanced Solid MalignanciesUnited States, Hong Kong, Canada
-
Oneness Biotech Co., Ltd.RecruitingAdvanced Solid MalignanciesTaiwan
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid MalignanciesUnited States, United Kingdom, Canada, Korea, Republic of
-
AstraZenecaActive, not recruiting
-
Eucure (Beijing) Biopharma Co., LtdCompletedAdvanced Solid MalignanciesAustralia
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid MalignanciesUnited States, Spain
-
AstraZenecaCompleted
-
Hanmi Pharmaceutical Company LimitedCompletedAdvanced Solid MalignanciesKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedAdvanced Solid MalignanciesKorea, Republic of
-
AstraZenecaCompletedAdvanced Solid MalignanciesRussian Federation, Germany
-
AstraZenecaCompleted
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
New Mexico Cancer Care AllianceCompletedAdvanced Solid Tumor MalignanciesUnited States
-
AstraZenecaTerminatedSolid Tumors | Advanced Solid Malignancies | Cancer,United States